We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Imaging Shows Radiation Resistance in Tumor Microenvironment

By MedImaging International staff writers
Posted on 18 Mar 2019
Print article
Image: Radiation-sensitive tumor (L), and radiation-resistant tumor (R). Sensitive tumors have more collagen (blue) (Photo courtesy of University of Arkansas).
Image: Radiation-sensitive tumor (L), and radiation-resistant tumor (R). Sensitive tumors have more collagen (blue) (Photo courtesy of University of Arkansas).
Noninvasive Raman spectroscopy could spare some patients the toxic side effects of ineffective radiation therapy (RT), claims a new study.

Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA) and the University of Arkansas (Fayetteville, USA) conducted a study to map radiation-induced biomolecular changes in tumors, and uncover the latent micro-environmental differences between RT-resistant and RT-sensitive tumors. To do so, the researchers cultured human head and neck squamous cell carcinoma (HNSCC) cell lines to grow tumor xenografts in mice, and then measured the molecular specificity and quantitative nature of Raman spectroscopic tissue assessments.

Labe-free Raman spectra obtained from untreated and treated tumors were subjected to chemometric analysis in order to quantify biomolecular differences in the tumor microenvironment. The results revealed statistically significant differences in lipid and collagen content that could potentially identify treatment-resistant tumors early on in the therapeutic regimen. Histological evaluation of the tumors was consistent with the Raman spectroscopic results. The study was published on February 28, 2019, in Cancer Research.

“Identifying patients with radiation-resistant tumors prior to commencing treatment or immediately after it has begun would significantly improve response rates and help these patients avoid the toxic side effects of ineffective radiation therapy,” said biomedical engineer Narasimhan Rajaram, PhD, of the University of Arkansas. “Our findings provide a rationale for translating these studies to patients with this as the ultimate goal.”

Raman spectroscopy is a form of molecular spectroscopy based on Raman scattering. When a beam of light interacts with a material, part of it is transmitted, part it is reflected, and part of it is scattered; over 99% of the scattered radiation has the same frequency as the incident beam, but a small portion of the scattered radiation has frequencies different from that of the incident beam. The scattered radiation contains information on the particular atoms or ions that comprise the molecule, the chemical bonds connect them, the symmetry of their molecule structure, and the physico-chemical environment where they reside.

Related Links:
Johns Hopkins University
University of Arkansas

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Brachytherapy Planning System
Oncentra Brachy
New
Pre-Op Planning Solution
Sectra 3D Trauma
PACS Workstation
CHILI Web Viewer

Print article

Channels

MRI

view channel
Image: Diamond dust offers a potential alternative to the widely used contrast agent gadolinium in MRI (Photo courtesy of Max Planck Institute)

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans

Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more